Strongbridge Biopharma plc to Present at the 27th Annual Oppenheimer Healthcare Conference and the 16th Annual Needham Healthcare Conference
DUBLIN, Ireland and TREVOSE, Pa., March 14, 2017 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that Matthew Pauls, president and chief executive officer, will present at the 27th Annual Oppenheimer Healthcare Conference and the 16th Annual Needham Healthcare Conference. The details of the conferences are as follows:
27th Annual Oppenheimer Healthcare Conference
16th Annual Needham Healthcare Conference
The Company’s presentations will be webcast live and archived on the “Events & Presentations” page in the Investor section of the Company’s website at www.strongbridgebio.com.
About Strongbridge Biopharma
Contacts Corporate and Media Relations Elixir Health Public Relations Lindsay Rocco +1 862-596-1304 firstname.lastname@example.org Investor Relations The Trout Group Marcy Nanus +1 646-378-2927 email@example.com USA 900 Northbrook Drive Suite 200 Trevose, PA 19053 Tel. +1 610-254-9200 Fax. +1 215-355-7389
Source: Strongbridge Biopharma